December 21st 2021
Jim Kenney, RPh, MBA; Kevin U. Stephens, Sr, JD, MD; Philip Niles, MD, MBA; and Nicholas G. Anderson, MD, review the clinical and economic burden of wet AMD and diabetic macular edema (DME), share currently available treatment options, and discuss considerations for emerging ophthalmic therapies.
December 20th 2021
Neil Minkoff, MD, provides a glimpse at an upcoming Peer Exchange featuring a panel of clinicians and managed care decision makers for a discussion on women’s reproductive health.
December 17th 2021
This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
December 16th 2021
Expert panelists provide an overview of clinical and managed care considerations in the treatment of glaucoma beyond the first line of therapy.
December 1st 2021
A panel of experts discuss their personalized approaches to treating patients with psoriasis and comorbidities such as metabolic syndrome.
November 18th 2021
A panel of experts share payer and clinical considerations for recurrent clostridium difficile infection, including recommend treatment pathways, unmet needs, and emerging therapies.
September 30th 2021
Clinician and payer insight regarding complexities managing patients with chronic kidney disease and type 2 diabetes, and best practices utilizing newer treatment options.
September 24th 2021
A discussion on the management of cold agglutinin disease, and the impact of emerging therapies in the pipeline on payer and clinician considerations.
August 30th 2021
A panel of experts highlight the burden of Alzheimer’s disease and current unmet needs related to diagnosis and treatment, discuss clinical and payer considerations for the diagnosis and management of AD, and generate discussion around future directions in the diagnosis and treatment.
August 11th 2021
Neil Minkoff, MD; Nihar R. Desai, MD, MPH; Jeffrey Turner, MD; and Om P. Ganda, MD, explore opportunities for improving population health outcomes in cardiorenal metabolic syndrome, including clinical and payer considerations of emerging diabetes treatments.